CD86 and neoplasm: Specifically, the quadruple combination showed the strongest reprogramming effects, reducing M2 markers (CD206, CD163) and increasing M1 markers (CD86, CD11c, HLA-DR) in the indirect co-culture with HCT116 cells, suggesting a shift toward anti-tumor immunity.